Abstract CP-005 Table 1

Deferasirox median dose, number of dose changes and SF during treatment and their relationship with adherence

Median dose (mg)Number of changes in dosageFinal serum ferritin (µg/L)
Adherent patients1125 (968, 1479)0.50 (0.00, 1.00)1204 (567, 1652)*
Non-adherent patients1240 (1150, 1406)1.00 (0.00, 1.00)1430 (955, 1815)*
  • Adherent patients= adherence ≥ 90%. Data is expressed as median (p25, p75).

  • * Statistically significant differences between adherent and non-adherent patients (p < 0.05).